• Skip to main content
  • Skip to navigation
Home

YEDA Technology Transfer from the Weizmann Institute of Science

Yeda Research and Development

Briefcase
Become a member
Menu
  • Home
  • About Us
    • About Us
    • Our Team
    • Board of Directors
    • Close
  • Technologies
    • Agriculture and Plant Genetics
    • Chemistry and Nanotechnology
    • Diagnostics
    • Environmental Sciences and Solar Energy
    • Mathematics and Computer Science
    • Medical Devices
    • Pharmaceuticals
    • Physics and Electro-Optics
    • Research Tools
    • Close
  • Success Stories
    • Products
    • Companies
    • Close
  • News & events
  • For researchers
  • Contact
  • Become a Member
  • Close
  • Technologies(140)
  • Research Experts(88)
  • Success Stories(47)
  • News & Events(57)

You are here

  1. Home ›
  2. Search ›
  3. Technologies

Results for technologies (5)

Advanced filter
Pharmaceuticals

Natural human antibodies to treat cancer (No. T4-2152)

Ovarian cancer is the fifth leading cause of cancer-related death in women. Due to a lack of early detection methods, it is often diagnosed at a late stage, resulting in negligible changes to cure. Ovarian carcinoma is the most lethal gynecological malignancy and the fifth leading... Read more
Full Professor Irit Sagi

Irit Sagi

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
17825
Pharmaceuticals

Protein Based Treatment for Duchene Muscular Dystrophy and Cancer (No. T4-1913)

Duchenne muscular dystrophy (DMD) is a disease that affects approximately 1 in 3,500 boys with a life expectancy of ~26 years. Duchenne muscular dystrophy (DMD) is a disease that causes progressive muscle weakness, loss of skeletal and heart muscle tissue, degeneration, and eventu... Read more
Full Professor Irit Sagi

Irit Sagi

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
6026
Pharmaceuticals

Antibody for Preventing/Treating Secondary Respiratory Infections (No. T4-1790)

A novel method of preventing secondary infections, by inhibition of membrane type I matrix-metalloproteinase-1, which reduces degradation of the extra cellular matrix. Pathogens that infect the respiratory system are the cause of some of the most dangerous infections, especially ... Read more
Full Professor Irit Sagi

Irit Sagi

Faculty of Biology

Associate Professor Ido Amit

Ido Amit

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
5647
Pharmaceuticals

Treating Cancer and Collagen-Associated Diseases by Using Anti-LOXL-2 Antibody (No. T4-1743)

An innovative method for treating diseases associated with dysregulation of collagen fibers in the extracellular matrix (ECM), such as cancer and fibrosis, by targeting LOXL-2. ECM disruption is associated with many pathological conditions, such as various cancer types and tissue... Read more
Full Professor Irit Sagi

Irit Sagi

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
5611
Pharmaceuticals

Antibody Based Therapy to Treat Cancer and GI Related Diseases (No. T4-1640)

A novel therapeutic antibody against MMP-7, with exceptional specificity, for the treatment of aggressive cancers. Matrix metalloproteins (MMPs), a family of zinc-dependent endopeptidases, are key enzymes participating in remodeling of the extracellular matrix (ECM), and are thus ... Read more
Full Professor Irit Sagi

Irit Sagi

Faculty of Biology

Share buttons
Share on facebook
Share on twitter
Share on Google +
Share with Email
5557

User login

  • Home
  • About Us
    • About Us
    • Our Team
    • Board of Directors
    • Close
  • Technologies
    • Agriculture and Plant Genetics
    • Chemistry and Nanotechnology
    • Diagnostics
    • Environmental Sciences and Solar Energy
    • Mathematics and Computer Science
    • Medical Devices
    • Pharmaceuticals
    • Physics and Electro-Optics
    • Research Tools
    • Close
  • Success Stories
    • Products
    • Companies
    • Close
  • News & events
  • For researchers
  • Contact
  • Become a Member
  • Close

footer

Yeda Research & Development Co. Ltd, P.O Box 95, Rehovot 7610002, Israel
Tel. +972.8.9470617 | Fax. +972.8.9470739
Privacy-Policy youtube twitter facebook linkedin instagram